An Open Label Extension Study of Ublituximab in Subjects With Relapsing Multiple Sclerosis

Condition:   Relapsing Multiple Sclerosis (RMS) Intervention:   Biological: Ublituximab Sponsor:   TG Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials